Type 2 Inflammation News

News

Type 2 Inflammation Linked With Persistent Allergic Disease

07/14/2023

“Identifying individuals at risk for continued rhinitis and asthma allows clinicians to better plan follow-up appointments and improve the selection of patients who might benefit from allergen immunotherapy or treatments targeting type 2...

“Identifying individuals at risk...

07/14/2023

First Report Managed Care

News

Dupilumab Reduces COPD Exacerbations in Patients With Type 2 Inflammation

07/07/2023

Jolynn Tumolo ;

“In some patients with COPD, type 2 inflammation may increase exacerbation risk and may be indicated by elevated blood eosinophil counts,” said researchers.

“In some patients with COPD,...

07/07/2023

First Report Managed Care

News

Monoclonal Antibody Improves Disease Control in Patients With Severe Asthma and CRSwNP

06/20/2023

Julie Gould ;

“Our results consolidate the strategic position of dupilumab in its role as an excellent therapeutic option currently available within the context of modern biological treatments of severe asthma and CRSwNP, frequently driven by type 2 airway...

“Our results consolidate the...

06/20/2023

First Report Managed Care

News

Therapy Improves Type 2 Asthma Outcomes Regardless of Allergic Status

06/09/2023

Jolynn Tumolo ;

Researchers found that long-term treatment with dupilumab improved outcomes in patients with moderate-to-severe GINA-based type 2 asthma, regardless of allergic status.

Researchers found that long-term...

06/09/2023

First Report Managed Care

News

Is Treatment for Type 2 Inflammation With Mepolizumab Beneficial?

05/22/2023

Julie Gould ;

Researchers studied the impact of mepolizumab on gene co-expression in airway eosinophils, mast cells, and epithelium among pediatric patients with asthma.

Researchers studied the impact...

05/22/2023

First Report Managed Care

News

Real-World Study Confirms Effectiveness, Safety of Therapy for CRSwNP

05/12/2023

Jolynn Tumolo ;

Researchers studied clinical outcomes and adverse events in patients with chronic rhinosinusitis with nasal polyps who received biweekly dupilumab.

Researchers studied clinical...

05/12/2023

First Report Managed Care

News

Monoclonal Antibody Improves Type 2 Inflammation Biomarkers in Children With Asthma

04/21/2023

Jolynn Tumolo ;

Findings from a phase 3 study suggest two dose regimens of a monoclonal antibody were similarly efficacious for reducing type 2 inflammatory biomarkers in pediatric patients with asthma.

Findings from a phase 3 study...

04/21/2023

First Report Managed Care

News

High Rate of Inflammation-Related Comorbidities in Patients With Type 2 Diseases

04/04/2023

Jolynn Tumolo ;

“The high comorbidity burden highlighted in this study, in terms of number and severity of type 2 inflammatory conditions, suggests the importance of identifying patients with type 2 inflammation,” researchers said.

“The high comorbidity burden...

04/04/2023

First Report Managed Care

News

Periostin Appears Promising Target for Atopic Dermatitis Therapy

03/03/2023

Jolynn Tumolo ;

Researchers found the inhibition of periostin, a downstream molecule of type 2 inflammation, eased itching and scratching.

Researchers found the inhibition...

03/03/2023

First Report Managed Care

News

Two Type 2 Inflammation Markers Elevated in Patients With Prurigo Nodularis

03/01/2023

Jolynn Tumolo ;

“Given the diversity of this disease, further biomarker studies may help elucidate future precision medicine approaches in the management of prurigo nodularis," researchers advised.

“Given the diversity of this...

03/01/2023

First Report Managed Care

Current Issue

September 2024

Volume 21

Issue 3

Current Issue

Issue Archive

What's Trending?

News

Palbociclib Combined with Letrozole Doubles PFS in Advanced Breast Cancer

11/21/2016

Recent data suggests that Ibrance (palbociclib; Pfizer) combined with letrozole nearly doubles progression-free survival in women with advanced estrogen-receptor (ER)-positive, HER2-negative breast cancer, compared with letrozole alone.

Recent data suggests that...

11/21/2016

First Report Managed Care

Cover Story

Can Cost-Plus Pricing Lower the Cost of Generic Drugs for Patients?

04/18/2022

Jeff Craven ;

With the ever-rising costs of medications, new business models and patient care initiatives are becoming increasingly common methods to disrupt the industry to instill lasting change. But how do these recent ventures, like Mark Cuban’s new...

With the ever-rising costs of...

04/18/2022

First Report Managed Care

Potential Issues Associated with Polypharmacy

10/22/2012

Tim Casey ;

Phoenix—For decades, clinicians prescribed an opioid or nonsteroidal anti-inflammatory drug (NSAID) to treat patients with chronic pain. Currently, they are much more likely to utilize a polypharmacy approach, using multiple drugs to achieve...

Phoenix—For decades, clinicians...

10/22/2012

First Report Managed Care

News

FDA panel OKs Novartis` pancreatic tumor drug

05/09/2011

First Report Managed Care

News

Senators appointed to commission that will monitor Va. Medicaid reforms

04/12/2013

First Report Managed Care

Video Insights

Videos

Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care

11/13/2024

David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...

David Sand, MD, MBA, chief...

11/13/2024

First Report Managed Care

Videos

The Evolving Role of CGRP-targeting Therapies in Migraine Prevention

10/31/2024

Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.

Richard Lipton, MD, provides...

10/31/2024

First Report Managed Care

Videos

Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer

09/26/2024

Alexander Spira , MD, PhD;

Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).

Alexander I. Spira, MD, PhD,...

09/26/2024

First Report Managed Care

Videos

Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives

09/25/2024

Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.

Learn about research...

09/25/2024

First Report Managed Care

Videos

Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable

09/04/2024

View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.

View a roundtable discussion on...

09/04/2024

First Report Managed Care

Videos

Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions

08/15/2024

Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...

Guest expert Jordan Bazinsky...

08/15/2024

First Report Managed Care

Videos

Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia

08/14/2024

Farrukh T. Awan , MD;

Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).

Farrukh Awan, MD, highlights...

08/14/2024

Journal of Clinical Pathways

Videos

Evolving Health Care Contact Centers Into Drivers of Value-Based Care

07/31/2024

Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.

Discover how health care contact...

07/31/2024

First Report Managed Care

Videos

Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024

06/11/2024

Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations

Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...

Key stakeholders in the health...

06/11/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

Type 2 Inflammation News

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

Specialties

Events

Year Round Education

HMP Global Products